Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease.

Literature DB >> 12162917

Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease.

Abstract

Radiotherapy, the first cancer treatment modality that offered cure, is still considered to be the most effective "single agent" in treating Hodgkin's disease (HD). Yet, the role of radiotherapy in HD has changed dramatically with the advent of effective combination chemotherapy and the rising concern of long-term complications associated with successful treatment of HD. The new principles of integrating radiotherapy into a combined-modality regimen for HD at different prognostic stages are reviewed here, along with the effect of this new role on radiation field size and design.

Entities: Disease

Mesh：

Substances：

Year: 2002 PMID： 12162917 DOI： 10.1007/s11912-002-0036-9

Source DB: PubMed Journal: Curr Oncol Rep ISSN： 1523-3790 Impact factor: 5.075

64 in total

1. A study of Hodgkin's disease treated by irradiation.

Authors: M V PETERS; K C MIDDLEMISS
Journal: Am J Roentgenol Radium Ther Nucl Med Date: 1958-01

2. Successful treatment of refractory Hodgkin's disease by high-dose combination chemotherapy and autologous bone marrow transplantation.

Authors: J G Gribben; D C Linch; C R Singer; A K McMillan; M Jarrett; A H Goldstone
Journal: Blood Date: 1989-01 Impact factor: 22.113

3. Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease.

Authors: A M Gianni; S Siena; M Bregni; F Lombardi; L Gandola; P Valagussa; G Bonadonna
Journal: Ann Oncol Date: 1991-10 Impact factor: 32.976

4. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.

Authors: A Santoro; S Viviani; C J Villarreal; V Bonfante; A Delfino; P Valagussa; G Bonadonna
Journal: Cancer Treat Rep Date: 1986-03

5. Impact of adjuvant radiation on the patterns and rate of relapse in advanced-stage Hodgkin's disease treated with alternating chemotherapy combinations.

Authors: J Yahalom; J Ryu; D J Straus; J J Gaynor; J Myers; J Caravelli; B D Clarkson; Z Fuks
Journal: J Clin Oncol Date: 1991-12 Impact factor: 44.544

6. Radical radiotherapy as salvage treatment for relapse of Hodgkin's disease initially treated by chemotherapy alone: prognostic significance of the disease-free interval.

Authors: R D Pezner; J A Lipsett; N Vora; S J Forman
Journal: Int J Radiat Oncol Biol Phys Date: 1994-11-15 Impact factor: 7.038

7. Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution.

Authors: G Biti; E Cellai; S M Magrini; M G Papi; P Ponticelli; V Boddi
Journal: Int J Radiat Oncol Biol Phys Date: 1994-04-30 Impact factor: 7.038

8. Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized study.

Authors: C J Fabian; C M Mansfield; S Dahlberg; S E Jones; T P Miller; E Van Slyck; P N Grozea; F S Morrison; C A Coltman; R I Fisher
Journal: Ann Intern Med Date: 1994-06-01 Impact factor: 25.391

9. Radiotherapy with curative intent: an option in selected patients relapsing after chemotherapy for advanced Hodgkin's disease.

Authors: M Roach; D S Kapp; S A Rosenberg; R T Hoppe
Journal: J Clin Oncol Date: 1987-04 Impact factor: 44.544